NWPF

News ArchivesRead News

A 3-D Light Switch for the Brain

Tuesday November 20, 2012

www.photonics.com - CAMBRIDGE, Mass., Nov. 19, 2012 — A new tool that delivers precise points of light to living brain tissue in three dimensions could one day help treat Parkinson’s disease and epilepsy; it could even aid in the understanding of consciousness and how memories form.

Biologists and engineers at MIT developed the three-dimensional “light switch” using a technique that manipulates neurons with light, known as optogenetics. The method, only a few years old, sensitizes select brain cells to a particular color of light. By illuminating precise areas of the brain, scientists can selectively activate or deactivate the individual neurons that have been sensitized.

Optogenetics allows scientists to play a more active role in probing the brain’s connections, to fire up one type of cell or deactivate another and then observe the effect on a behavior, such as quieting a seizure. “You can see neural activity in the brain that is associated with specific behaviors, but is it important?” said Ed Boyden, a synthetic biologist at MIT and a pioneer in the field of optogenetics. “Or is it a passive copy of important activity located elsewhere in the brain? There’s no way to know for sure if you just watch.”

ntire circuits within the brain can now be explored with the new 3-D tool, which so far has been tested on mice. The 3-D array is precise enough to activate a single kind of neuron, at a precise location, with a single beam of light; previous techniques did not have the same precision. Probes delivering electricity to the brain could manipulate neurons, but they cannot target individual kinds of cells, Boyden said. Drugs can turn neurons on or off, but not on such a quick time scale, nor with such a high degree of control.

A previous version of Boyden’s device looked like a needle-thin probe with light-emitting ports along its length; these ports allowed scientists to manipulate neurons along a single line. The new tool contains up to 100 of these probes — each just 150 µm across — in a square grid, so the device looks like a series of fine-toothed combs laid next to each other with their teeth pointing in the same direction.

By adding a third dimension to the light-delivery capabilities, researchers can make any pattern of light they want within the volume of a cubic centimeter of brain tissue, using a few hundred independently controllable illumination points. The implants do not cause any discomfort because the brain lacks pain receptors.

Neurons in the brain are not naturally responsive to light, so scientists sensitize these cells with molecules called opsins, light-detecting proteins naturally found in bacteria and algae. Different colors of light turn on different flavors of opsin.

An individual neuron’s response depends on the type of opsin it was sensitized with and the color of light used to illuminate it. This gives neuroscientists an unprecedented level of control over individual neurons in the brain, and could be used to study the memory process, the difference between being awake and asleep, and the connections between memory and emotion.

A better understanding of the brain may lead to another benefit: therapy. If particular types of cells malfunction in a particular disease, scientists may be able to use a modified 3-D array as a neural prosthesis that could help treat the neurological condition. For example, light could be used to stop overactive cells from firing, alleviating the uncontrollable muscle action of Parkinson’s disease. Implants that correct hearing deficiencies also are being explored with this method.

While the new device is effective in bringing light to the brain, challenges must be overcome before optogenetics can be used for medical therapy, Boyden said. Scientists are still investigating whether the body will detect the opsin proteins as foreign molecules and reject them; gene therapy also will have to prove itself if neurons are to be effectively sensitized with opsin.

The findings appeared in Optics Letters.

For more information, visit: www.mit.edu

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression